Patents
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
12/2004
12/16/2004WO2004108747A2 Lectin conjugates
12/16/2004US20040254342 Substrates and assays for beta-secretase
12/16/2004US20040254341 Human aspartyl protease peptide for use in identifying modulators for treatment and prevention of neurodegenerative and nervous system disorders; enzyme inhibitors
12/16/2004US20040253706 Substrates and assays for beta-secretase
12/16/2004US20040253612 Selection of proteins using RNA-protein fusions
12/08/2004CN1178905C Novel peptide derivative
12/02/2004WO2004103270A2 Compounds and methods for treatment of thrombosis
12/02/2004WO2004103266A2 Protein kinase c peptides for use in withdrawal
12/02/2004US20040241792 Substrates and assays for beta-secretase
12/02/2004CA2524818A1 Protein kinase c peptides for use in withdrawal
12/01/2004EP1481011A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
11/2004
11/25/2004WO2004101504A1 Stereoselective method of preparing gamma-amino vinyl sulphones
11/25/2004WO2004093662A3 Method for detecting prognosis of cancer
11/24/2004EP1479692A1 Peptides responsive to antibodies against a consensus peptide of the CS4-CFA/I family proteins
11/18/2004WO2004048591A3 Methods for cohort selection and longevity studies
11/17/2004EP1476746A2 Method for discovering pharmacologically active substances
11/17/2004CN1546521A Transfer factor specific for SARS virus and method for preparing same
11/17/2004CN1546515A Immune RNA specific for SARS virus and method for preparing same
11/17/2004CN1546496A Method for separation and purification of lecithin and cephalin
11/04/2004WO2004094644A2 Vibrio cholerae proteins expressed during infection
11/04/2004WO2004094600A2 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
11/04/2004WO2004093807A2 Somatostatin vectors
11/04/2004WO2004093662A2 Method for detecting prognosis of cancer
11/04/2004US20040219203 Anti-CD74 immunoconjugates and methods
11/04/2004CA2523197A1 Peptide vectors
11/04/2004CA2522400A1 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
11/03/2004EP1471936A2 Hiv vaccine and method of use
11/02/2004US6811970 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
10/2004
10/28/2004WO2004091490A2 Somatostatin-dopamine chimeric analogs
10/28/2004CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004CA2521965A1 Somatostatin-dopamine chimeric analogs
10/26/2004US6808882 Isolating preferential nucleotide sequences; obtain nucleotide sequence samples, encapsulate into microcapsules, monitor gene expression activities
10/21/2004WO2004090548A1 Device for analysis or separation containing an active nanostructured carrier, its preparation method and applications
10/21/2004WO2004089297A2 Compounds and methods for treatment of thrombosis
10/20/2004EP1468392A2 Method for binding site identification using a multi-scale approach
10/20/2004EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS
10/20/2004EP0959895B1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
10/14/2004CA2520381A1 Proteolytic and covalent antibodies
10/13/2004EP1465659A2 Use of a novel cell surface protease from group b streptococcus
10/13/2004CN1170853C Method for extracting biological protein powder
09/2004
09/30/2004WO2004083154A1 Improved extraction process
09/30/2004WO2004037164A3 Crosslinked compounds and methods of making and using thereof
09/30/2004CA2518722A1 Improved extraction process
09/29/2004CN1168711C Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use
09/23/2004WO2004080412A2 Paclitaxel hybrid derivatives
09/23/2004US20040185504 Microplate thermal shift assay apparatus for ligand development and multi-variable protein chemistry optimization
09/22/2004EP1460084A1 Novel peptide sy
09/16/2004WO2004047762A3 Methods for treating cancer using porimin as a target
09/15/2004EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY
09/10/2004WO2004058803A3 Peptides that bind of the vegfr-2
09/09/2004US20040175700 Using phenotypic, genotypic, physiological and morphogenic variation profiles to diagnose and prognose genetic disorders; genomics
09/08/2004EP1453534A1 A process for the preparation of a non-toxic anthrax vaccine
09/08/2004CN1527719A Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis
09/02/2004CA2753408A1 Production of modified glycoproteins having multiple antennary structures
09/01/2004EP1451207A2 Labeling reagent and methods of use
08/2004
08/26/2004WO2004072105A2 Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods
08/26/2004WO2004071414A2 Therapeutic anti-hcv (al9) compounds
08/26/2004WO2004018684A3 T-cell epitopes in staphylococcal enterotoxin b
08/25/2004CN1163515C Novel affinity chromatography medium and purification method for cobra neurotoxin
08/18/2004EP1446426A2 Peptide purification by means of metal ion affinity chromatography
08/18/2004EP1446415A2 Detection and identification of enteric bacteria
08/18/2004CN1521188A Protein extracted from perinereis aibuhitensis, its preparation method and use
08/12/2004WO2004041182A3 M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
08/12/2004US20040156865 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever
08/11/2004EP1444267A2 Affinity enhancement agents
08/11/2004CN1161614C Corticotropin releasing factor receptor-1 deficient mice, and method of dertermination agonist agent and antagonist
08/05/2004WO2004065547A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
08/05/2004WO2004065409A2 Peptide mimotopes of lipooligosaccharide from nontypeable haemophilus influenzae as vaccines
08/05/2004CA2513308A1 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
08/04/2004EP1343371A4 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
07/2004
07/29/2004US20040147728 Method for increasing hydrophilicity of fluorescent label compounds
07/20/2004CA2103148C Determination of motifs of peptides on mhc molecules
07/15/2004WO2004058803A2 Peptides that bind of the vegfr-2
07/07/2004CN1156490C High-purity biliprotein separating process
07/01/2004US20040126841 Novel G-protein coupled receptor, HLTEX11
06/2004
06/30/2004EP1432826A2 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid
06/30/2004EP0686161B1 Novel human beta2 integrin alpha subunit
06/10/2004WO2004048591A2 Methods for cohort selection and longevity studies
06/10/2004WO2004047762A2 Methods for treating cancer using porimin as a target
06/10/2004CA2507215A1 Methods for treating cancer using porimin as a target
06/10/2004CA2485950A1 Methods for cohort selection and longevity studies
06/09/2004EP1425295A1 Modified peptides and their use for the treatment of autoimmune diseases
06/09/2004CN1503680A Ascorbic a cid analogs for metalloradiopharmaceuticals
06/09/2004CN1502624A Method for preparnig functional protein powder by usnig waste water produced by processing fish powder
06/09/2004CN1152887C Hydrolytic active substance of brain protein, its preparing process and its activity and sequence
06/02/2004EP1423135A2 Methods for inhibiting angiogenesis
06/02/2004CN1152047C Process for extracting thallus from waste liquid of monosodium glutamate
05/2004
05/26/2004EP1421220A2 Method and nucleic acids for the analysis of colon cancer
05/21/2004WO2004041182A2 M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
05/19/2004EP1419393A1 Tumor specific oligosaccharide sequences and use thereof
05/19/2004EP1304116A4 New class of bioactive glycoprotein
05/19/2004EP1151143A4 Selection of proteins using rna-protein fusions
05/19/2004CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies
05/12/2004EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies
05/12/2004CN1494919A Embonate medicine composition containing bombesin-like product
05/06/2004WO2004037164A2 Crosslinked compounds and methods of making and using thereof
05/06/2004US20040087768 Process for rapid solution synthesis of peptides
05/06/2004US20040087504 Novel peptide sy
05/06/2004EP1415006A2 Assay for identifying inhibitors of hiv rt dimerization
04/2004
04/29/2004US20040082760 Process for rapid solution synthesis of peptides
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 48